[Anti-CD19 chimeric antigen receptors T cells for treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: three cases report and literatures review]
- PMID: 29551033
- PMCID: PMC7343108
- DOI: 10.3760/cma.j.issn.0253-2727.2018.01.010
[Anti-CD19 chimeric antigen receptors T cells for treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: three cases report and literatures review]
Similar articles
-
Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases.Leuk Lymphoma. 2019 Jun;60(6):1454-1461. doi: 10.1080/10428194.2018.1533127. Epub 2019 Feb 4. Leuk Lymphoma. 2019. PMID: 30714847
-
Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia.Blood. 1992 Apr 1;79(7):1781-8. Blood. 1992. PMID: 1348433
-
Rational design of an immunoconjugate for selective knock-down of leukemia-specific E2A-PBX1 fusion gene expression in human Pre-B leukemia.Integr Biol (Camb). 2013 Jan;5(1):122-32. doi: 10.1039/c2ib20114c. Integr Biol (Camb). 2013. PMID: 22990208
-
A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia.J Oncol Pharm Pract. 2018 Sep;24(6):453-467. doi: 10.1177/1078155217713363. Epub 2017 Jun 5. J Oncol Pharm Pract. 2018. PMID: 28583018 Review.
-
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL).Ther Adv Hematol. 2015 Oct;6(5):228-41. doi: 10.1177/2040620715588916. Ther Adv Hematol. 2015. PMID: 26425336 Free PMC article. Review.
References
-
- Crist WM, Carroll AJ, Shuster JJ, et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study[J] Blood. 1990;76(1):117–122. - PubMed
-
- Rambaldi A, Attuati V, Bassan R, et al. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia[J] Leuk Lymphoma. 1996;21(5-6):457–466. doi: 10.3109/10428199609093444. - DOI - PubMed
-
- Vey N, Thomas X, Picard C, et al. Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study[J] Leukemia. 2006;20(12):2155–2161. doi: 10.1038/sj.leu.2404420. - DOI - PubMed